ReP USP - Resultado da busca

Artigo de periodico
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia (2023)
Catto, Luiz Fernando Bazzo ; Zanelatto, Leonardo C.; Donaires, Flávia Sacilotto ; Carvalho, Vinícius Silva de; Santana, Bárbara Amélia Aparecida ; Pinto, André L.; Fantacini, Daianne; Souza, Lucas Eduardo Botelho de ; Fonseca, Natasha Peixoto ; Telho, Bruno S.; Madeira, Maria Isabel Ayrosa; Pagnano, Katia Borgia Barbosa; Firmato, Ana Beatriz; Fagundes, Evandro Maranhão; Higashi, Márcia; Nunes, Elenaide Coutinho; Traina, Fabiola ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Calado, Rodrigo Tocantins
Source: Blood Advances. Unidades: FMRP, FM
Subjects: LINHAGEM CELULAR, LEUCEMIA MIELOIDE AGUDA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATTO, Luiz Fernando Bazzo et al. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Advances, v. 7, n. 22, p. 7067-7078, 2023Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2023010658. Acesso em: 10 nov. 2024.
APA
Catto, L. F. B., Zanelatto, L. C., Donaires, F. S., Carvalho, V. S. de, Santana, B. A. A., Pinto, A. L., et al. (2023). Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia. Blood Advances, 7( 22), 7067-7078. doi:10.1182/bloodadvances.2023010658
NLM
Catto LFB, Zanelatto LC, Donaires FS, Carvalho VS de, Santana BAA, Pinto AL, Fantacini D, Souza LEB de, Fonseca NP, Telho BS, Madeira MIA, Pagnano KBB, Firmato AB, Fagundes EM, Higashi M, Nunes EC, Traina F, Pontes LL de F, Rego EM, Calado RT. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia [Internet]. Blood Advances. 2023 ; 7( 22): 7067-7078.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1182/bloodadvances.2023010658
Vancouver
Catto LFB, Zanelatto LC, Donaires FS, Carvalho VS de, Santana BAA, Pinto AL, Fantacini D, Souza LEB de, Fonseca NP, Telho BS, Madeira MIA, Pagnano KBB, Firmato AB, Fagundes EM, Higashi M, Nunes EC, Traina F, Pontes LL de F, Rego EM, Calado RT. Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia [Internet]. Blood Advances. 2023 ; 7( 22): 7067-7078.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1182/bloodadvances.2023010658
Artigo de periodico
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients (2022)
Pontelli, Marjorie C.; Castro, Ítalo A.; Martins, Ronaldo B; La Serra, Leonardo; Veras, Flávio P.; Nascimento, Daniele C; Silva, Camila M.; Cardoso, Ricardo S; Rosales, Roberta Ribeiro Costa; Gomes, Rogério; Lima, Thais M.; Souza, Juliano P.; Vitti, Brenda C.; Caetité, Diego B.; Lima, Mikhael Haruo Fernandes de; Stumpf, Spencer D; Thompson, Cassandra E; Bloyet, Louis-Marie; Toller-Kawahisa, Juliana E.; Giannini, Marcela C.; Bonjorno, Letícia P; Lopes, Maria Isabel Fernandes; Batah, Sabrina Setembre; Siyuan, Li; Luppino-Assad, Rodrigo; Almeida, Sergio C L; Oliveira, Fabiola R; Benatti, Maíra N; Pontes, Lorena Lobo de Figueiredo; Santana, Rodrigo Carvalho; Vilar, Fernando C; Auxiliadora-Martins, Maria; Shi, Pei-Yong; Cunha, Thiago Mattar; Calado, Rodrigo Tocantins; Alves-Filho, José Carlos; Zamboni, Dario Simões; Fabro, Alexandre Todorovic; Louzada Júnior, Paulo; Oliveira, Renê Donizete Ribeiro; Whelan, Sean P J; Cunha, Fernando Queiróz; Arruda, Eurico
Source: Journal of Molecular Cell Biology. Unidades: FCFRP, FMRP
Subjects: COVID-19, LINFÓCITOS, MONÓCITOS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTELLI, Marjorie C. et al. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. Journal of Molecular Cell Biology, v. 14, n. 4, 2022Tradução . . Disponível em: https://doi.org/10.1093/jmcb/mjac021. Acesso em: 10 nov. 2024.
APA
Pontelli, M. C., Castro, Í. A., Martins, R. B., La Serra, L., Veras, F. P., Nascimento, D. C., et al. (2022). SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. Journal of Molecular Cell Biology, 14( 4). doi:10.1093/jmcb/mjac021
NLM
Pontelli MC, Castro ÍA, Martins RB, La Serra L, Veras FP, Nascimento DC, Silva CM, Cardoso RS, Rosales RRC, Gomes R, Lima TM, Souza JP, Vitti BC, Caetité DB, Lima MHF de, Stumpf SD, Thompson CE, Bloyet L-M, Toller-Kawahisa JE, Giannini MC, Bonjorno LP, Lopes MIF, Batah SS, Siyuan L, Luppino-Assad R, Almeida SCL, Oliveira FR, Benatti MN, Pontes LL de F, Santana RC, Vilar FC, Auxiliadora-Martins M, Shi P-Y, Cunha TM, Calado RT, Alves-Filho JC, Zamboni DS, Fabro AT, Louzada Júnior P, Oliveira RDR, Whelan SPJ, Cunha FQ, Arruda E. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients [Internet]. Journal of Molecular Cell Biology. 2022 ; 14( 4):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/jmcb/mjac021
Vancouver
Pontelli MC, Castro ÍA, Martins RB, La Serra L, Veras FP, Nascimento DC, Silva CM, Cardoso RS, Rosales RRC, Gomes R, Lima TM, Souza JP, Vitti BC, Caetité DB, Lima MHF de, Stumpf SD, Thompson CE, Bloyet L-M, Toller-Kawahisa JE, Giannini MC, Bonjorno LP, Lopes MIF, Batah SS, Siyuan L, Luppino-Assad R, Almeida SCL, Oliveira FR, Benatti MN, Pontes LL de F, Santana RC, Vilar FC, Auxiliadora-Martins M, Shi P-Y, Cunha TM, Calado RT, Alves-Filho JC, Zamboni DS, Fabro AT, Louzada Júnior P, Oliveira RDR, Whelan SPJ, Cunha FQ, Arruda E. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients [Internet]. Journal of Molecular Cell Biology. 2022 ; 14( 4):[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/jmcb/mjac021
Artigo de periodico
Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms (2022)
Costa, Amanda Fernandes de Oliveira ; Marani, Leticia Olops ; Bianco, Thiago Mantello ; Arantes, Adriana Queiroz; Lopes, Izabela Aparecida; Martins, Diego Antonio Pereira; Palma, Leonardo Carvalho ; Scheucher, Priscila Santos ; Schiavinato, Josiane Lilian dos Santos ; Silva, Cleide Lucia Araújo ; Kobayashi, Susumu S. ; Machado Neto, João Agostinho ; Rego, Eduardo Magalhães ; Welner, Robert Samuel; Pontes, Lorena Lobo de Figueiredo
Source: Frontiers in Immunology. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, MUTAÇÃO, CITOMETRIA DE FLUXO, CÉLULAS CULTIVADAS DE TUMOR, CÉLULAS DA MEDULA ÓSSEA, LEUCEMIA, CÉLULAS SANGUÍNEAS, MEDULA ÓSSEA, CÉLULAS-TRONCO, LINFÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Amanda Fernandes de Oliveira et al. Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms. Frontiers in Immunology, v. 13, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.768592. Acesso em: 10 nov. 2024.
APA
Costa, A. F. de O., Marani, L. O., Bianco, T. M., Arantes, A. Q., Lopes, I. A., Martins, D. A. P., et al. (2022). Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.768592
NLM
Costa AF de O, Marani LO, Bianco TM, Arantes AQ, Lopes IA, Martins DAP, Palma LC, Scheucher PS, Schiavinato JL dos S, Silva CLA, Kobayashi SS, Machado Neto JA, Rego EM, Welner RS, Pontes LL de F. Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3389/fimmu.2022.768592
Vancouver
Costa AF de O, Marani LO, Bianco TM, Arantes AQ, Lopes IA, Martins DAP, Palma LC, Scheucher PS, Schiavinato JL dos S, Silva CLA, Kobayashi SS, Machado Neto JA, Rego EM, Welner RS, Pontes LL de F. Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 nov. 10 ] Available from: https://doi.org/10.3389/fimmu.2022.768592
Artigo de periodico-carta/editorial
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax (2022)
Lima, Keli Cristina de ; Vicari, Hugo Passos ; Carlos, Jorge Antonio Elias Godoy; Silva, Jean Carlos Lipreri da ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, APOPTOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2021.01.004. Acesso em: 10 nov. 2024. , 2022
APA
Lima, K. C. de, Vicari, H. P., Carlos, J. A. E. G., Silva, J. C. L. da, Pontes, L. L. de F., Rego, E. M., & Machado Neto, J. A. (2022). Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2021.01.004
NLM
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Vancouver
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Artigo de periodico
Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms (2022)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Pereira, Luiz Miguel ; Berzoti-Coelho, Maria Gabriela ; Berbel, Giovana Michelassi; Baroni, Luciana ; Pereira, Tathiane Maistro Malta ; Tognon, Raquel; Nunes, Natália de Souza ; Souto, Elizabeth Xisto; Pontes, Lorena Lobo de Figueiredo ; Natsui, Ana Patrícia Yatsuda ; Castro, Fabíola Attié de
Source: Medical Oncology. Unidades: FCFRP, FMRP, ESALQ, FFCLRP, IQ
Subjects: APOPTOSE, EXPRESSÃO GÊNICA, HIPOTÁLAMO, NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms. Medical Oncology, v. 39, n. 5, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12032-022-01696-x. Acesso em: 10 nov. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Pereira, L. M., Berzoti-Coelho, M. G., Berbel, G. M., Baroni, L., et al. (2022). Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms. Medical Oncology, 39( 5), 1-11. doi:10.1007/s12032-022-01696-x
NLM
Cacemiro M da C, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Pereira TMM, Tognon R, Nunes N de S, Souto EX, Pontes LL de F, Natsui APY, Castro FA de. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms [Internet]. Medical Oncology. 2022 ; 39( 5): 1-11.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s12032-022-01696-x
Vancouver
Cacemiro M da C, Cominal JG, Pereira LM, Berzoti-Coelho MG, Berbel GM, Baroni L, Pereira TMM, Tognon R, Nunes N de S, Souto EX, Pontes LL de F, Natsui APY, Castro FA de. Hippo pathway-related genes expression is deregulated in myeloproliferative neoplasms [Internet]. Medical Oncology. 2022 ; 39( 5): 1-11.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s12032-022-01696-x
Artigo de periodico
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells (2021)
Vicari, Hugo Passos ; Silva, Juan Luiz Coelho da ; Martins, Diego Antonio Pereira ; Araujo, Antônio Roberto Lucena de ; Lima, Keli Cristina de ; Silva, Jean Carlos Lipreri da ; Scheucher, Priscila Santos ; Koury, Luisa C.; Melo, Raul A. de ; Bittencourt, Rosane; Pagnano, Katia ; Nunes, Elenaide ; Fagundes, Evandro Maranhão ; Kerbauy, Fabio; Pontes, Lorena Lobo de Figueiredo ; Costa-Lotufo, Letícia Veras ; Rego, Eduardo Magalhães ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Investigational New Drugs. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, CÉLULAS SANGUÍNEAS, CLONAGEM, LEUCEMIA MIELOIDE AGUDA, ONCOPROTEÍNAS, CÉLULAS MIELOIDES, CICLO CELULAR, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICARI, Hugo Passos et al. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells. Investigational New Drugs, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10637-021-01197-0. Acesso em: 10 nov. 2024.
APA
Vicari, H. P., Silva, J. L. C. da, Martins, D. A. P., Araujo, A. R. L. de, Lima, K. C. de, Silva, J. C. L. da, et al. (2021). STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells. Investigational New Drugs, 1-15. doi:10.1007/s10637-021-01197-0
NLM
Vicari HP, Silva JLC da, Martins DAP, Araujo ARL de, Lima KC de, Silva JCL da, Scheucher PS, Koury LC, Melo RA de, Bittencourt R, Pagnano K, Nunes E, Fagundes EM, Kerbauy F, Pontes LL de F, Costa-Lotufo LV, Rego EM, Traina F, Machado Neto JA. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells [Internet]. Investigational New Drugs. 2021 ; 1-15.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s10637-021-01197-0
Vancouver
Vicari HP, Silva JLC da, Martins DAP, Araujo ARL de, Lima KC de, Silva JCL da, Scheucher PS, Koury LC, Melo RA de, Bittencourt R, Pagnano K, Nunes E, Fagundes EM, Kerbauy F, Pontes LL de F, Costa-Lotufo LV, Rego EM, Traina F, Machado Neto JA. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells [Internet]. Investigational New Drugs. 2021 ; 1-15.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s10637-021-01197-0
Artigo de periodico
Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma (2021)
Pontes, Lorena Lobo de Figueiredo; Adamcova, Miroslava K.; Grusanovic, Srdjan; Kuzmina, Maria; Lopes, Izabela Aparecida; Costa, Amanda Fernandes de Oliveira; Zhang, Hong; Strnad, Hynek; Lee, Sanghoon; Moudra, Alena; Jonasova, Anna T.; Zidka, Michal; Welner, Robert S.; Tenen, Daniel G.; Alberich-Jorda, Meritxell
Source: Stem Cell Reports. Unidade: FMRP
Subjects: PROTEÍNAS, CÉLULAS CULTIVADAS, EXPRESSÃO GÊNICA, CÉLULAS-TRONCO, INTERFERONS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTES, Lorena Lobo de Figueiredo et al. Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma. Stem Cell Reports, v. 16, n. 8, p. 1999-2013, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.stemcr.2021.06.008. Acesso em: 10 nov. 2024.
APA
Pontes, L. L. de F., Adamcova, M. K., Grusanovic, S., Kuzmina, M., Lopes, I. A., Costa, A. F. de O., et al. (2021). Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma. Stem Cell Reports, 16( 8), 1999-2013. doi:10.1016/j.stemcr.2021.06.008
NLM
Pontes LL de F, Adamcova MK, Grusanovic S, Kuzmina M, Lopes IA, Costa AF de O, Zhang H, Strnad H, Lee S, Moudra A, Jonasova AT, Zidka M, Welner RS, Tenen DG, Alberich-Jorda M. Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma [Internet]. Stem Cell Reports. 2021 ; 16( 8): 1999-2013.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.stemcr.2021.06.008
Vancouver
Pontes LL de F, Adamcova MK, Grusanovic S, Kuzmina M, Lopes IA, Costa AF de O, Zhang H, Strnad H, Lee S, Moudra A, Jonasova AT, Zidka M, Welner RS, Tenen DG, Alberich-Jorda M. Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma [Internet]. Stem Cell Reports. 2021 ; 16( 8): 1999-2013.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.stemcr.2021.06.008
Artigo de periodico
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia (2021)
Ribeiro, Renata Scopim ; Machado Neto, João Agostinho ; Eide, Christopher A. ; Silva, Juan Luiz Coelho da ; Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Scheucher, Priscila Santos ; Stevens, Samantha L. Savage ; Campos, Paula de Melo; Saad, Sara T. Olalla ; Palma, Leonardo de Carvalho ; Pontes, Lorena Lobo de Figueiredo ; Simões, Belinda Pinto ; Rego, Eduardo Magalhães ; Tognon, Cristina E. ; Druker, Brian J. ; Traina, Fabiola
Source: Investigational New Drugs. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE, INSULINA, ANTINEOPLÁSICOS, PROTEÍNAS QUINASES, CÉLULAS SANGUÍNEAS, PROLIFERAÇÃO CELULAR, APOPTOSE, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Renata Scopim et al. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, v. 39, n. 3, p. 736-746, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10637-020-01028-8. Acesso em: 10 nov. 2024.
APA
Ribeiro, R. S., Machado Neto, J. A., Eide, C. A., Silva, J. L. C. da, Fenerich, B. A., Fernandes, J. C., et al. (2021). NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, 39( 3), 736-746. doi:10.1007/s10637-020-01028-8
NLM
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Vancouver
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Trabalho de evento-resumo periodico
Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients (2020)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Pontes, Lorena Lobo de Figueiredo ; Sorgi, Carlos Arterio ; Faccioli, Lucia Helena ; Castro, Fabíola Attié de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FFCLRP, FCFRP
Subjects: NEOPLASIAS, MEDULA ÓSSEA, POLICITEMIA, TROMBOCITOSE, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.197. Acesso em: 10 nov. 2024. , 2020
APA
Cacemiro, M. da C., Cominal, J. G., Pontes, L. L. de F., Sorgi, C. A., Faccioli, L. H., & Castro, F. A. de. (2020). Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.197
NLM
Cacemiro M da C, Cominal JG, Pontes LL de F, Sorgi CA, Faccioli LH, Castro FA de. Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S117.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.197
Vancouver
Cacemiro M da C, Cominal JG, Pontes LL de F, Sorgi CA, Faccioli LH, Castro FA de. Arachidonic acid (aa)-derived lipid mediators are increased in the bone marrow plasma from polycythemia vera and essential thrombocythemia patients [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S117.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.197
Trabalho de evento-resumo periodico
Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients (2020)
Cominal, Juçara Gastaldi; Cacemiro, Maira da Costa ; Sorgi, Carlos Arterio ; Faccioli, Lucia Helena ; Pontes, Lorena Lobo de Figueiredo ; Castro, Fabíola Attié de
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FFCLRP, FCFRP, FMRP
Subjects: TROMBOCITOSE, TRANSTORNOS MIELOPROLIFERATIVOS, ÁCIDOS GRAXOS ESSENCIAIS, LIPÍDEOS, MEDULA ÓSSEA, EICOSANOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMINAL, Juçara Gastaldi et al. Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.201. Acesso em: 10 nov. 2024. , 2020
APA
Cominal, J. G., Cacemiro, M. da C., Sorgi, C. A., Faccioli, L. H., Pontes, L. L. de F., & Castro, F. A. de. (2020). Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.201
NLM
Cominal JG, Cacemiro M da C, Sorgi CA, Faccioli LH, Pontes LL de F, Castro FA de. Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S119-S120.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.201
Vancouver
Cominal JG, Cacemiro M da C, Sorgi CA, Faccioli LH, Pontes LL de F, Castro FA de. Deregulation of bone marrow eicosanoids in essential thrombocythemia and primary myelofibrosis patients [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S119-S120.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.201
Artigo de periodico-carta/editorial
Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta] (2020)
Costa, Victor E. F.; Oliveira, Rafael D.; Traina, Fabiola ; Chahud, Fernando ; Palma, Leonardo Carvalho; Pontes, Lorena Lobo de Figueiredo
Source: British Journal of Haematology. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE, TROMBOCITOSE, MUTAÇÃO GENÉTICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Victor E. F. et al. Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]. British Journal of Haematology. Chichester: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bjh.16274. Acesso em: 10 nov. 2024. , 2020
APA
Costa, V. E. F., Oliveira, R. D., Traina, F., Chahud, F., Palma, L. C., & Pontes, L. L. de F. (2020). Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta]. British Journal of Haematology. Chichester: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/bjh.16274
NLM
Costa VEF, Oliveira RD, Traina F, Chahud F, Palma LC, Pontes LL de F. Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta] [Internet]. British Journal of Haematology. 2020 ; 188( 3): e21-e23.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/bjh.16274
Vancouver
Costa VEF, Oliveira RD, Traina F, Chahud F, Palma LC, Pontes LL de F. Co-occurrence of BCR–ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia [Carta] [Internet]. British Journal of Haematology. 2020 ; 188( 3): e21-e23.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/bjh.16274
Trabalho de evento-resumo periodico
Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution (2020)
Ruiz, M. R.; Pontes, Lorena Lobo de Figueiredo; Pontes Neto, Octávio Marques; Silva, João Paulo Lettieri da; Garibaldi, P. M. M.; Traina, Fabiola; Palma, L. C.
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidade: FMRP
Subjects: TRANSTORNOS MIELOPROLIFERATIVOS, HEMATOLOGIA, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, M. R. et al. Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.209. Acesso em: 10 nov. 2024. , 2020
APA
Ruiz, M. R., Pontes, L. L. de F., Pontes Neto, O. M., Silva, J. P. L. da, Garibaldi, P. M. M., Traina, F., & Palma, L. C. (2020). Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.209
NLM
Ruiz MR, Pontes LL de F, Pontes Neto OM, Silva JPL da, Garibaldi PMM, Traina F, Palma LC. Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S124.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.209
Vancouver
Ruiz MR, Pontes LL de F, Pontes Neto OM, Silva JPL da, Garibaldi PMM, Traina F, Palma LC. Ischemic stroke in patients with philadelphia-negative classical myeloproliferative neoplasms: epidemiology and risk factors in a single center institution [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S124.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.209
Trabalho de evento-resumo periodico
Association of natural killer cells functional subtypes with genetic risk stratification in acute myeloid leukemia (2020)
Costa, A. F. O.; Marani, Leticia Olops; Jacovelli, Gustavo Leite; Coelho, J. L.; Bianco, Thiago Mantello; Lopes, Izabela Aparecida; Scheucher, Priscila Santos; Schiavinato, Josiane Lilian dos Santos ; Pagnano, K.; Duarte, B. K.; Kerbauy, Fábio Rodrigues; Higashi, M.; Nunes, E.; Fagundes, E.; Gloria, A. B. F.; Rego, Eduardo Magalhães; Traina, Fabiola; Pontes, Lorena Lobo de Figueiredo
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FM
Subjects: LEUCEMIA MIELOIDE AGUDA, SISTEMA IMUNE, MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. F. O. et al. Association of natural killer cells functional subtypes with genetic risk stratification in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.243. Acesso em: 10 nov. 2024. , 2020
APA
Costa, A. F. O., Marani, L. O., Jacovelli, G. L., Coelho, J. L., Bianco, T. M., Lopes, I. A., et al. (2020). Association of natural killer cells functional subtypes with genetic risk stratification in acute myeloid leukemia. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.243
NLM
Costa AFO, Marani LO, Jacovelli GL, Coelho JL, Bianco TM, Lopes IA, Scheucher PS, Schiavinato JL dos S, Pagnano K, Duarte BK, Kerbauy FR, Higashi M, Nunes E, Fagundes E, Gloria ABF, Rego EM, Traina F, Pontes LL de F. Association of natural killer cells functional subtypes with genetic risk stratification in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S143-S144.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.243
Vancouver
Costa AFO, Marani LO, Jacovelli GL, Coelho JL, Bianco TM, Lopes IA, Scheucher PS, Schiavinato JL dos S, Pagnano K, Duarte BK, Kerbauy FR, Higashi M, Nunes E, Fagundes E, Gloria ABF, Rego EM, Traina F, Pontes LL de F. Association of natural killer cells functional subtypes with genetic risk stratification in acute myeloid leukemia [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S143-S144.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.243
Trabalho de evento-resumo periodico
High frequency of leukemic stem cells is associated with adverse prognosis in a Brazilian cohort of acute myeloid leukemia with normal karyotype (2020)
Jacovelli, Gustavo Leite; Costa, A. F. O.; Marani, Leticia Olops; Madeira, M. I. A.; Scheucher, Priscila Santos; Silva, F. B.; Lima, Ana Silvia Gouvêa de; Duarte, B .K.; Pagnano, K. B.; Kerbauy, Fábio Rodrigues; Feliciano, J. V.P.; Higashi, M.; Nunes, E. C.; Fagundes, E. M.; Gloria, A. B. F.; Rego, Eduardo Magalhães; Traina, Fabiola; Pontes, Lorena Lobo de Figueiredo
Source: Hematology, Transfusion and Cell Therapy. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular - HemoPlay. Unidades: FMRP, FM
Subjects: HEMATOLOGIA, LEUCEMIA, MEDULA ÓSSEA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOVELLI, Gustavo Leite et al. High frequency of leukemic stem cells is associated with adverse prognosis in a Brazilian cohort of acute myeloid leukemia with normal karyotype. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2020.10.259. Acesso em: 10 nov. 2024. , 2020
APA
Jacovelli, G. L., Costa, A. F. O., Marani, L. O., Madeira, M. I. A., Scheucher, P. S., Silva, F. B., et al. (2020). High frequency of leukemic stem cells is associated with adverse prognosis in a Brazilian cohort of acute myeloid leukemia with normal karyotype. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2020.10.259
NLM
Jacovelli GL, Costa AFO, Marani LO, Madeira MIA, Scheucher PS, Silva FB, Lima ASG de, Duarte B .K, Pagnano KB, Kerbauy FR, Feliciano JVP, Higashi M, Nunes EC, Fagundes EM, Gloria ABF, Rego EM, Traina F, Pontes LL de F. High frequency of leukemic stem cells is associated with adverse prognosis in a Brazilian cohort of acute myeloid leukemia with normal karyotype [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S153-S154.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.259
Vancouver
Jacovelli GL, Costa AFO, Marani LO, Madeira MIA, Scheucher PS, Silva FB, Lima ASG de, Duarte B .K, Pagnano KB, Kerbauy FR, Feliciano JVP, Higashi M, Nunes EC, Fagundes EM, Gloria ABF, Rego EM, Traina F, Pontes LL de F. High frequency of leukemic stem cells is associated with adverse prognosis in a Brazilian cohort of acute myeloid leukemia with normal karyotype [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42 S153-S154.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2020.10.259
Artigo de periodico
Differential cytokine network profile in polycythemia vera and secondary polycythemia (2020)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Coelho, Maria Gabriela Berzoti; Tognon, Raquel; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pereira, Ítalo Sousa; Sartori, Daniela Carlos ; Faccioli, Lucia Helena ; Pontes, Lorena Lobo de Figueiredo ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: INTERLEUCINAS, TRANSTORNOS MIELOPROLIFERATIVOS, FISIOPATOLOGIA, CITOCINAS, NEOPLASIAS, MORTALIDADE, TROMBOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, v. 10, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41598-020-63680-7. Acesso em: 10 nov. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Coelho, M. G. B., Tognon, R., Nunes, N. de S., Simões, B. P., et al. (2020). Differential cytokine network profile in polycythemia vera and secondary polycythemia. Scientific Reports, 10, 1-7. doi:10.1038/s41598-020-63680-7
NLM
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Vancouver
Cacemiro M da C, Cominal JG, Coelho MGB, Tognon R, Nunes N de S, Simões BP, Pereira ÍS, Sartori DC, Faccioli LH, Pontes LL de F, Frantz FG, Castro FA de. Differential cytokine network profile in polycythemia vera and secondary polycythemia [Internet]. Scientific Reports. 2020 ; 10 1-7.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1038/s41598-020-63680-7
Artigo de periodico-carta/editorial
Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] (2019)
Sousa, Juliana Cordeiro; Ito, Mayumi Nóbrega; Costa, Marilia Braga; Farias, Izabelle Rocha; Borges, Daniela Paula; Oliveira, Roberta Taiane; Fukutani, Kiyoshi Ferreira; Thomé, Carolina Hassibe ; Martinelli, Camila Maria Silva; Myajima, Fabio; Vidal, Daniel Onofre; Magalhães, Silvia Maria Meira; Pontes, Lorena Lobo de Figueiredo ; Pinheiro, Ronald Feitosa
Source: Hematological Oncology. Unidade: FMRP
Subjects: HEMATOLOGIA, CÉLULAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Juliana Cordeiro et al. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hon.2608. Acesso em: 10 nov. 2024. , 2019
APA
Sousa, J. C., Ito, M. N., Costa, M. B., Farias, I. R., Borges, D. P., Oliveira, R. T., et al. (2019). Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta]. Hematological Oncology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/hon.2608
NLM
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/hon.2608
Vancouver
Sousa JC, Ito MN, Costa MB, Farias IR, Borges DP, Oliveira RT, Fukutani KF, Thomé CH, Martinelli CMS, Myajima F, Vidal DO, Magalhães SMM, Pontes LL de F, Pinheiro RF. Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis. [Carta] [Internet]. Hematological Oncology. 2019 ; 37( 4): 523-526.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/hon.2608
Artigo de periodico
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation (2018)
Cacemiro, Maira da Costa ; Cominal, Juçara Gastaldi ; Tognon, Raquel ; Nunes, Natália de Souza ; Simões, Belinda Pinto ; Pontes, Lorena Lobo de Figueiredo ; Catto, Luiz Fernando Bazzo ; Traina, Fabiola ; Souto, Elizabeth Xisto; Zambuzi, Fabiana Albani ; Frantz, Fabiani Gai ; Castro, Fabíola Attié de
Source: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, INFLAMAÇÃO, CITOCINAS, CÉLULAS MIELOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematology, Transfusion and Cell Therapy, v. 40, n. 2, p. 120-131, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2017.12.003. Acesso em: 10 nov. 2024.
APA
Cacemiro, M. da C., Cominal, J. G., Tognon, R., Nunes, N. de S., Simões, B. P., Pontes, L. L. de F., et al. (2018). Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation. Hematology, Transfusion and Cell Therapy, 40( 2), 120-131. doi:10.1016/j.htct.2017.12.003
NLM
Cacemiro M da C, Cominal JG, Tognon R, Nunes N de S, Simões BP, Pontes LL de F, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 2): 120-131.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2017.12.003
Vancouver
Cacemiro M da C, Cominal JG, Tognon R, Nunes N de S, Simões BP, Pontes LL de F, Catto LFB, Traina F, Souto EX, Zambuzi FA, Frantz FG, Castro FA de. Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation [Internet]. Hematology, Transfusion and Cell Therapy. 2018 ; 40( 2): 120-131.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.htct.2017.12.003
Trabalho de evento-resumo periodico
Hippo pathway deregulation in myeloproliferative neoplasms (2017)
Cacemiro, Maira da Costa; Cominal, Juçara Gastaldi; Souto, Elizabeth Xisto; Traina, Fabiola; Pontes, Lorena Lobo de Figueiredo; Simões, Belinda Pinto; Castro, Fabíola Attié de
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO 2017). Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, LEUCEMIA, PROLIFERAÇÃO CELULAR, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACEMIRO, Maira da Costa et al. Hippo pathway deregulation in myeloproliferative neoplasms. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf. Acesso em: 10 nov. 2024. , 2017
APA
Cacemiro, M. da C., Cominal, J. G., Souto, E. X., Traina, F., Pontes, L. L. de F., Simões, B. P., & Castro, F. A. de. (2017). Hippo pathway deregulation in myeloproliferative neoplasms. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
NLM
Cacemiro M da C, Cominal JG, Souto EX, Traina F, Pontes LL de F, Simões BP, Castro FA de. Hippo pathway deregulation in myeloproliferative neoplasms [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39 S160-S161.[citado 2024 nov. 10 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
Vancouver
Cacemiro M da C, Cominal JG, Souto EX, Traina F, Pontes LL de F, Simões BP, Castro FA de. Hippo pathway deregulation in myeloproliferative neoplasms [Internet]. Revista Brasileira de Hematologia e Hemoterapia. 2017 ; 39 S160-S161.[citado 2024 nov. 10 ] Available from: https://www.abhheventos.com.br/hemo2017/wp-content/uploads/2014/01/SUPLEMENTO-HEMO-2017.pdf
Artigo de periodico
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression (2016)
Yong, Kol Jia; Bassères, Daniela Sanchez ; Welner, Robert S; Zhang, Wen Cai; Yang, Henry; Yan, Benedict; Jorda, Meritxell Alberich; Zhang, Junyan; Pontes, Lorena Lobo de Figueiredo; Battelli, Chiara; Hetherington, Christopher J; Ye, Min; Zhang, Hong; Maroni, Giorgia; O'Brien, Karen; Magli, Maria Cristina; Borczuk, Alain C; Varticovski, Lyuba; Kocher, Olivier; Zhang, Pu; Moon, Young-Choon; Sydorenko, Nadiya; Cao, Liangxian; Davis, Thomas W; Thakkar, Bhavin M; Soo, Ross A; Iwama, Atsushi; Lim, Bing; Halmos, Balazs; Neuberg, Donna; Tenen, Daniel G; Levantini, Elena
Source: Science Translational Medicine. Unidade: IQ
Subjects: NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YONG, Kol Jia et al. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, v. 8, n. 350, p. 1-10 art. 350ra104, 2016Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aad6066. Acesso em: 10 nov. 2024.
APA
Yong, K. J., Bassères, D. S., Welner, R. S., Zhang, W. C., Yang, H., Yan, B., et al. (2016). Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, 8( 350), 1-10 art. 350ra104. doi:10.1126/scitranslmed.aad6066
NLM
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
Vancouver
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
Artigo de periodico
Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia (2012)
Oliveira, Fábio Morato de; Pontes, Lorena Lobo de Figueiredo; Bassi, Sarah Cristina; Dalmazzo, Leandro Felipe Figueiredo; Falcao, Roberto Passetto
Source: Medical Oncology. Unidade: FMRP
Subjects: LEUCEMIA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Fábio Morato de et al. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia. Medical Oncology, v. 29, n. 2, p. 1227-1230, 2012Tradução . . Disponível em: https://doi.org/10.1007/s12032-011-9957-1. Acesso em: 10 nov. 2024.
APA
Oliveira, F. M. de, Pontes, L. L. de F., Bassi, S. C., Dalmazzo, L. F. F., & Falcao, R. P. (2012). Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia. Medical Oncology, 29( 2), 1227-1230. doi:10.1007/s12032-011-9957-1
NLM
Oliveira FM de, Pontes LL de F, Bassi SC, Dalmazzo LFF, Falcao RP. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1227-1230.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s12032-011-9957-1
Vancouver
Oliveira FM de, Pontes LL de F, Bassi SC, Dalmazzo LFF, Falcao RP. Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia [Internet]. Medical Oncology. 2012 ; 29( 2): 1227-1230.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s12032-011-9957-1

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration